Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma

Objective: The stratification of neuroblastoma (NBL) prognosis remains difficult. RNA-based signatures might be able to predict prognosis, but independent cross-platform validation is still rare. Methods: RNA-Seq-based profiles from NBL patients were acquired and then analyzed. The RNA-Seq prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jian-Guo, Liang, Bo, Jin, Su-Han, Liao, Hui-Ling, Du, Guo-Bo, Cheng, Long, Ma, Hu, Gaipl, Udo S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904333/
https://www.ncbi.nlm.nih.gov/pubmed/31867276
http://dx.doi.org/10.3389/fonc.2019.01361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904333/
https://www.ncbi.nlm.nih.gov/pubmed/31867276
http://dx.doi.org/10.3389/fonc.2019.01361

Ejemplares similares